mechlorethamine has been researched along with Recrudescence in 112 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 7.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "Mechlorethamine has been assessed in 28 patients with idiopathic nephrotic syndrome previously treated with prednisone only." | 7.67 | [Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood]. ( Canals, MJ; Cervera, A; Gómez Campderá, FJ; Gómez Campderá, J; López Gómez, JM; Luque, A; Morales, JL, 1984) |
| "Complete responses lasting from 4 to 14 years were documented in 65 of 331 (20%) patients with cutaneous T cell lymphoma treated with topical mechlorethamine (HN2) between 1968 and 1982." | 7.67 | Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. ( Kantor, AF; Micaily, B; Shrager, L; Tan, ET; Van Scott, EJ; Vonderheid, EC, 1989) |
| "The use of topical mechlorethamine hydrochloride in the treatment of skin disease has been restricted because of the frequent development of contact dermatitis." | 7.66 | The treatment of mycosis fungoides with ointment-based mechlorethamine. ( Deneau, DG; Hoppe, RT; Price, NM, 1982) |
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 3.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "Mechlorethamine has been assessed in 28 patients with idiopathic nephrotic syndrome previously treated with prednisone only." | 3.67 | [Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood]. ( Canals, MJ; Cervera, A; Gómez Campderá, FJ; Gómez Campderá, J; López Gómez, JM; Luque, A; Morales, JL, 1984) |
| "Complete responses lasting from 4 to 14 years were documented in 65 of 331 (20%) patients with cutaneous T cell lymphoma treated with topical mechlorethamine (HN2) between 1968 and 1982." | 3.67 | Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. ( Kantor, AF; Micaily, B; Shrager, L; Tan, ET; Van Scott, EJ; Vonderheid, EC, 1989) |
| "The use of topical mechlorethamine hydrochloride in the treatment of skin disease has been restricted because of the frequent development of contact dermatitis." | 3.66 | The treatment of mycosis fungoides with ointment-based mechlorethamine. ( Deneau, DG; Hoppe, RT; Price, NM, 1982) |
| "One hundred patients with Hodgkin's disease (97 with stage I-II disease at presentation) who relapsed after radiation therapy alone were salvaged with either MOPP or ABVD." | 2.71 | Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease. ( Fisher, DC; Li, S; Mauch, PM; Neuberg, D; Ng, AK; Silver, B; Stevenson, MA, 2004) |
| "Of our 19 patients with Hodgkin's disease (age range, 6 to 20 years) treated with this regimen, 2 had clinical stage I disease, 10 had stage II, 6 had stage III, and 1 had stage IV." | 2.67 | Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. ( Arndt, CA; Chen, MG; Gilchrist, GS; Khan, SP; Matsumoto, JM; O'Fallon, WM; Schomberg, PJ; Smithson, WA, 1994) |
| "Relapses were most frequent in previously involved unirradiated areas." | 2.67 | Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience. ( Breed, WP; Burgers, JM; Carde, P; de Pauw, BE; Hagenbeek, A; Henry-Amar, M; Monconduit, M; Somers, R; Tarayre, M; Thomas, J, 1991) |
| "In patients with stage IV Hodgkin's disease mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) was randomly tested against MOPP alternated monthly with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)." | 2.66 | Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. ( Bonadonna, G; Santoro, A; Valagussa, P, 1986) |
| "From 1976 to 1981, 335 patients with untreated Hodgkin's disease, clinical stages I, II, and IIIA, have been treated by MOPP (nitrogen mustard, vincristine, procarbazine, prednisone) chemotherapy, three to six cycles according to the prognostic factors, combined with radiotherapy." | 2.66 | Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. ( Audebert, A; Bernadou, A; Diebold, J; Eghbali, H; Hoerni, B; Krulik, M; Merle-Béral, H; Parlier, Y; Rojouan, J; Zittoun, R, 1985) |
| "In most patients with newly diagnosed Hodgkin's disease, initial therapy is curative." | 2.39 | Hodgkin's disease: management of first relapse. ( Horning, SJ; Yuen, AR, 1996) |
| "Patients with advanced Hodgkin's disease not achieving a complete remission with initial MOPP therapy are significantly less responsive to adriamycin and nitrosourea-containing regimens than patients with relapsing disease following a complete remission with MOPP." | 2.37 | Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment. ( Coleman, M; Friedlander, RJ, 1988) |
| "This supports, that parapsoriasis is not a distinct entity, but an early stage of MF." | 1.39 | Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis. ( Fenger-Gron, M; Iversen, L; Lindahl, LM, 2013) |
| "The behavior of Hodgkin's lymphoma (HL) is different in developing countries, perhaps due to differences in epidemiology and population access to health care." | 1.35 | Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. ( Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA, 2009) |
| "Of 6 patients who developed recurrence, 3 (7." | 1.33 | [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. ( Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ, 2006) |
| "Hypopigmented mycosis fungoides is characterized by early onset, occurrence in dark-skinned individuals, and good response to therapy." | 1.31 | Hypopigmented mycosis fungoides: treatment and a 6(1/2)-year follow-up of 9 patients. ( Akaraphanth, R; Douglass, MC; Lim, HW, 2000) |
| "We transplanted 42 patients with Hodgkin's disease between 1990-1998." | 1.31 | [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. ( Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O, 2000) |
| "Patients with Hodgkin's disease whose initial complete remissions (CR) after primary chemotherapy were longer than 1 year are thought to have better prognoses than patients whose initial remissions were shorter than 1 year." | 1.29 | Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy. ( Aversa, SM; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Pappagallo, GL; Salvagno, L; Sorarù, M, 1993) |
| "The association of Hodgkin's disease and minimal-change nephrotic syndrome is well established." | 1.29 | The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease. ( Delmez, JA; Kissane, JM; Safdar, SH, 1994) |
| "Forty-nine patients with Hodgkin's disease who relapsed after a first complete remission of more than 12 months following primary chemotherapy were treated with salvage therapy regimens." | 1.28 | Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. ( Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S, 1990) |
| " There were three fatal toxic events, two due to viral infection and one to a second malignant tumor (NHL)." | 1.28 | Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. ( Berry, M; Blanchette, V; Chan, H; Doherty, M; Doyle, J; Freedman, M; Greenberg, M; Jenkin, D; Panzarella, T; Saunders, F, 1990) |
| "Twenty-seven children with Hodgkin's disease were treated with MVOPP (mustine, Velban [vinblastine], Oncovin [vincristine], procarbazine, prednisone) combination chemotherapy." | 1.27 | Hodgkin's disease in children. A ten-year experience in South Africa. ( Hartley, P; Jacobs, P; Karabus, C; King, HS; Werner, D, 1984) |
| "Appropriate management of Hodgkin's disease is based on both the stage of disease and the specific anatomic sites of involvement within each stage." | 1.27 | Diagnosis and management of Hodgkin's disease in the adult. ( Fuller, LM; Hagemeister, FB, 1983) |
| "Of 157 patients with Hodgkin's disease treated between 1970 and 1981 an assessment of the clinical course was possible in 134 cases." | 1.27 | [Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)]. ( Denz, H; Huber, H; Lechleitner, M; Peer, L; Peschel, C, 1983) |
| "Relapse was more frequent (29 out of 32 cases) in the involved parts of the lymphatic system which had not been exposed to radiation during complete remission." | 1.27 | [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy]. ( Kharatishvili, ZV; Kolygin, BA, 1983) |
| "There was no significant difference in recurrence rates between patients without mediastinal mass and patients with a small mass, and in these patients adjuvant chemotherapy MOPP after radiotherapy showed an evident benefit in reducing the relapse rate." | 1.27 | Prognostic significance of large mediastinal involvement in Hodgkin's disease. ( Baccarani, M; Cantore, M; Dominici, G; Emiliani, E; Faedi, M; Fiacchini, M; Frezza, G; Lauria, F; Mazza, P; Sciascia, R, 1983) |
| "The site of relapse is discussed in detail in the text." | 1.27 | Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure. ( Chan, PY; Hintz, BL; Kagan, AR; McMahon, J; Nussbaum, H; Rao, AR; Ryoo, MC; Wollin, M, 1987) |
| "The results of treatment of I-II stage Hodgkin's disease in children aged 2-14 have been studied." | 1.27 | [The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children]. ( Chikrizov, SI; Kanaev, SV; Kolygin, BA; Malinin, AP, 1986) |
| "Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available." | 1.26 | Childhood Hodgkin's disease in Uganda: a ten year experience. ( Katongole-Mbidde, E; Kiire, C; Lwanga, SK; Magrath, I; Olweny, CL; Ziegler, JL, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 56 (50.00) | 18.7374 |
| 1990's | 33 (29.46) | 18.2507 |
| 2000's | 19 (16.96) | 29.6817 |
| 2010's | 3 (2.68) | 24.3611 |
| 2020's | 1 (0.89) | 2.80 |
| Authors | Studies |
|---|---|
| Zawati, I | 1 |
| Adouni, O | 1 |
| Finetti, P | 1 |
| Manai, M | 2 |
| Gamoudi, A | 1 |
| Birnbaum, D | 1 |
| Bertucci, F | 1 |
| Mezlini, A | 1 |
| Back, AR | 1 |
| Schleis, SE | 1 |
| Smrkovski, OA | 1 |
| Lee, J | 1 |
| Smith, AN | 1 |
| Phillips, JC | 1 |
| Englund, A | 1 |
| Hopstadius, C | 1 |
| Enblad, G | 1 |
| Gustafsson, G | 1 |
| Ljungman, G | 1 |
| Souza, EM | 1 |
| Baiocchi, OC | 1 |
| Zanichelli, MA | 1 |
| Alves, AC | 1 |
| Oliveira, JS | 1 |
| Lindahl, LM | 1 |
| Fenger-Gron, M | 1 |
| Iversen, L | 1 |
| Hodgson, DC | 1 |
| Tsang, RW | 1 |
| Pintilie, M | 1 |
| Sun, A | 1 |
| Wells, W | 1 |
| Crump, M | 1 |
| Gospodarowicz, MK | 1 |
| Mandigers, CM | 1 |
| Verdonck, LF | 1 |
| Meijerink, JP | 1 |
| Dekker, AW | 2 |
| Schattenberg, AV | 1 |
| Raemaekers, JM | 1 |
| Ng, AK | 1 |
| Li, S | 1 |
| Neuberg, D | 1 |
| Silver, B | 3 |
| Stevenson, MA | 1 |
| Fisher, DC | 1 |
| Mauch, PM | 1 |
| Vassilakopoulos, TP | 1 |
| Angelopoulou, MK | 1 |
| Siakantaris, MP | 1 |
| Kontopidou, FN | 1 |
| Dimopoulou, MN | 1 |
| Kokoris, SI | 1 |
| Kyrtsonis, MC | 1 |
| Tsaftaridis, P | 1 |
| Karkantaris, C | 1 |
| Anargyrou, K | 1 |
| Boutsis, DE | 1 |
| Variamis, E | 1 |
| Michalopoulos, T | 1 |
| Boussiotis, VA | 1 |
| Panayiotidis, P | 1 |
| Papavassiliou, C | 1 |
| Pangalis, GA | 1 |
| Aversa, SM | 2 |
| Salvagno, L | 2 |
| Sorarù, M | 2 |
| Mazzarotto, R | 1 |
| Boso, C | 1 |
| Gaion, F | 1 |
| Chiarion-Sileni, V | 1 |
| De Franchis, G | 1 |
| Favaretto, AG | 1 |
| Crivellari, G | 1 |
| Banna, GL | 1 |
| Sotti, G | 1 |
| Monfardini, S | 1 |
| Balwierz, W | 2 |
| Moryl-Bujakowska, A | 2 |
| Depowska, T | 2 |
| Klekawka, T | 1 |
| Stanuch, H | 1 |
| Matysiak, M | 2 |
| Sopyło, B | 2 |
| Kołakowska-Mrozowska, B | 2 |
| Krenke, K | 1 |
| Chybicka, A | 1 |
| Raś, M | 1 |
| Sońta-Jakimczyk, D | 2 |
| Moszant, A | 1 |
| Wachowiak, J | 1 |
| Kaczmarek-Kanold, M | 2 |
| Kowalczyk, J | 2 |
| Odój, T | 1 |
| Balcerska, A | 1 |
| Drozyńska, E | 1 |
| Wysocki, M | 1 |
| Kołtan, A | 1 |
| Krawczuk-Rybak, M | 1 |
| Stolarska, M | 1 |
| Wessels, G | 1 |
| Bernard Hesseling, P | 1 |
| Campbell, B | 1 |
| Wirth, A | 1 |
| Milner, A | 1 |
| Di Iulio, J | 1 |
| MacManus, M | 1 |
| Ryan, G | 1 |
| Morbidini-Gaffney, S | 1 |
| Alpert, TE | 1 |
| Hatoum, GF | 1 |
| Sagerman, RH | 1 |
| Fermé, C | 2 |
| Mounier, N | 1 |
| Casasnovas, O | 1 |
| Brice, P | 2 |
| Divine, M | 1 |
| Sonet, A | 1 |
| Bouafia, F | 1 |
| Bastard-Stamatoullas, A | 1 |
| Bordessoule, D | 1 |
| Voillat, L | 1 |
| Reman, O | 1 |
| Blanc, M | 1 |
| Gisselbrecht, C | 1 |
| Wang, WH | 1 |
| Li, YX | 1 |
| Song, YW | 1 |
| Jin, J | 1 |
| Liu, YP | 1 |
| Wang, SL | 1 |
| Zhou, LQ | 1 |
| Liu, XF | 1 |
| Yu, ZH | 1 |
| Han, JZ | 1 |
| Majhail, NS | 1 |
| Weisdorf, DJ | 1 |
| Defor, TE | 1 |
| Miller, JS | 1 |
| McGlave, PB | 1 |
| Slungaard, A | 1 |
| Arora, M | 1 |
| Ramsay, NK | 1 |
| Orchard, PJ | 1 |
| MacMillan, ML | 1 |
| Burns, LJ | 1 |
| Advani, R | 1 |
| Maeda, L | 1 |
| Lavori, P | 1 |
| Quon, A | 1 |
| Hoppe, R | 1 |
| Breslin, S | 1 |
| Rosenberg, SA | 4 |
| Horning, SJ | 2 |
| Sutcliffe, SB | 2 |
| Economopoulos, T | 1 |
| Wrigley, PF | 3 |
| Stansfeld, AG | 1 |
| Malpas, JS | 2 |
| Anderson, H | 2 |
| Deakin, DP | 1 |
| Wagstaff, J | 2 |
| Jones, JM | 1 |
| Todd, ID | 1 |
| Wilkinson, PM | 1 |
| James, RD | 1 |
| Steward, WP | 1 |
| Blackledge, G | 2 |
| Scarffe, JH | 2 |
| Cooper, MR | 1 |
| Pajak, TF | 1 |
| Gottlieb, AJ | 1 |
| Glicksman, AS | 1 |
| Nissen, N | 1 |
| Richards, F | 1 |
| Bloomfield, C | 1 |
| Holland, JF | 1 |
| Crowther, D | 2 |
| Deakin, D | 1 |
| Todd, I | 1 |
| Wilkinson, P | 1 |
| Jones, M | 1 |
| Gómez Campderá, FJ | 1 |
| López Gómez, JM | 1 |
| Cervera, A | 1 |
| Gómez Campderá, J | 1 |
| Canals, MJ | 1 |
| Morales, JL | 1 |
| Luque, A | 1 |
| Jacobs, P | 1 |
| King, HS | 1 |
| Karabus, C | 1 |
| Hartley, P | 1 |
| Werner, D | 1 |
| Kovryzhkina, TA | 1 |
| Bayle-Weisgerber, C | 1 |
| Lemercier, N | 1 |
| Teillet, F | 1 |
| Asselain, B | 1 |
| Gout, M | 1 |
| Schweisguth, O | 1 |
| Armata, J | 2 |
| Borkowski, W | 1 |
| Fuller, LM | 3 |
| Hagemeister, FB | 2 |
| Denz, H | 1 |
| Lechleitner, M | 1 |
| Peschel, C | 1 |
| Peer, L | 1 |
| Huber, H | 1 |
| Kolygin, BA | 2 |
| Kharatishvili, ZV | 1 |
| Wagener, DJ | 1 |
| Burgers, JM | 3 |
| Kazem, I | 1 |
| van Peperzeel, HA | 1 |
| Qasim, MM | 1 |
| Sizoo, W | 1 |
| Somers, R | 2 |
| Kroese, WF | 1 |
| Mazza, P | 1 |
| Lauria, F | 2 |
| Sciascia, R | 2 |
| Emiliani, E | 2 |
| Fiacchini, M | 2 |
| Baccarani, M | 2 |
| Frezza, G | 1 |
| Dominici, G | 1 |
| Cantore, M | 1 |
| Faedi, M | 1 |
| Schoeneman, MJ | 1 |
| Spitzer, A | 1 |
| Greifer, I | 1 |
| Cadman, E | 1 |
| Bloom, AF | 1 |
| Prosnitz, L | 1 |
| Farber, L | 1 |
| Vera, R | 1 |
| Bertino, J | 1 |
| Fischer, D | 1 |
| Lawrence, R | 1 |
| Biedowa, J | 1 |
| Knychalska-Karwan, Z | 1 |
| Price, NM | 1 |
| Deneau, DG | 1 |
| Hoppe, RT | 4 |
| Millar, JW | 2 |
| Hunter, AM | 1 |
| Horne, NW | 2 |
| McLoud, TC | 1 |
| Isler, R | 1 |
| Head, J | 1 |
| Brusamolino, E | 1 |
| Orlandi, E | 1 |
| Canevari, A | 1 |
| Morra, E | 1 |
| Castelli, G | 1 |
| Alessandrino, EP | 1 |
| Pagnucco, G | 1 |
| Bernasconi, P | 1 |
| Astori, C | 1 |
| Lazzarino, M | 1 |
| Khan, SP | 1 |
| Gilchrist, GS | 1 |
| Arndt, CA | 1 |
| Smithson, WA | 1 |
| Chen, MG | 1 |
| Schomberg, PJ | 1 |
| Matsumoto, JM | 1 |
| O'Fallon, WM | 1 |
| Canellos, GP | 4 |
| Petroni, GR | 1 |
| Barcos, M | 1 |
| Duggan, DB | 1 |
| Peterson, BA | 1 |
| Uematsu, M | 1 |
| Tarbell, NJ | 2 |
| Coleman, CN | 1 |
| Rosenthal, DS | 2 |
| Shulman, LN | 1 |
| Canellos, G | 1 |
| Weinstein, H | 2 |
| Mauch, P | 2 |
| Bader, SB | 1 |
| Bianco, A | 1 |
| Chiarion Sileni, V | 1 |
| Pappagallo, GL | 1 |
| Fiorentino, MV | 1 |
| Baxter, JD | 1 |
| DiNubile, MJ | 1 |
| Delmez, JA | 1 |
| Safdar, SH | 1 |
| Kissane, JM | 1 |
| Arumugam, R | 1 |
| Watson, AR | 1 |
| Abdallah, JM | 1 |
| Lombardi, DP | 1 |
| Kirsch, IR | 1 |
| Nishikawa, K | 1 |
| Yuen, AR | 1 |
| Raez, LE | 1 |
| Temple, JD | 1 |
| Saldana, M | 1 |
| Redei, I | 1 |
| Mangan, KF | 1 |
| Ming, PL | 1 |
| Mullaney, MT | 1 |
| Rao, PN | 1 |
| Goldberg, SL | 1 |
| Klumpp, TR | 1 |
| Gerlach, B | 1 |
| Stein, A | 1 |
| Fischer, R | 1 |
| Wozel, G | 1 |
| Dittert, DD | 1 |
| Richter, G | 1 |
| Viviani, S | 3 |
| Camerini, E | 1 |
| Bonfante, V | 2 |
| Santoro, A | 4 |
| Balzarotti, M | 1 |
| Fornier, M | 1 |
| Devizzi, L | 1 |
| Verderio, P | 1 |
| Valagussa, P | 4 |
| Bonadonna, G | 4 |
| Lemoli, RM | 1 |
| Visani, G | 1 |
| Leopardi, G | 1 |
| Motta, MR | 1 |
| Rizzi, S | 1 |
| Testoni, N | 1 |
| Curti, A | 1 |
| Tura, S | 2 |
| Bogusławska-Jaworska, J | 1 |
| Pisarek, J | 1 |
| Janik-Moszant, A | 1 |
| Rokicka-Milewska, R | 1 |
| Kołecki, P | 1 |
| Skomra, S | 1 |
| Newecka-Samól, T | 1 |
| Fouillard, L | 1 |
| Laporte, J | 1 |
| Douay, L | 1 |
| Lesage, S | 1 |
| Najman, A | 1 |
| Gourmelon, P | 1 |
| Gorin, NC | 1 |
| Akaraphanth, R | 1 |
| Douglass, MC | 1 |
| Lim, HW | 1 |
| Avigdor, A | 1 |
| Hardan, I | 1 |
| Shpilberg, O | 1 |
| Raanani, P | 1 |
| Grotto, I | 1 |
| Ben-Bassat, I | 1 |
| Maslovsky, I | 1 |
| Volchek, L | 1 |
| Blumental, R | 1 |
| Ducach, A | 1 |
| Lugassy, G | 1 |
| Miller, AM | 1 |
| McPhaden, AR | 1 |
| Wadsworth, RM | 1 |
| Wainwright, CL | 1 |
| Chen, YC | 1 |
| Ho, CL | 1 |
| Kao, WY | 1 |
| Hwang, JM | 1 |
| Sheu, LF | 1 |
| Chao, TY | 1 |
| Porzig, KJ | 1 |
| Portlock, CS | 2 |
| Robertson, A | 1 |
| Kaplan, HS | 2 |
| Glatstein, EJ | 1 |
| Meyler, TS | 1 |
| Blumberg, AL | 1 |
| Purser, P | 1 |
| Botnick, LE | 1 |
| Goodman, R | 1 |
| Jaffe, N | 1 |
| Filler, R | 1 |
| Cassady, JR | 1 |
| Levi, JA | 1 |
| Wiernik, PH | 1 |
| Madoc-Jones, H | 1 |
| Gamble, JF | 1 |
| Butler, JJ | 1 |
| Sullivan, MP | 1 |
| Fernandez, CH | 1 |
| Gehan, EA | 1 |
| Smith, PG | 1 |
| Wald, N | 1 |
| Jenkin, D | 2 |
| Freedman, M | 2 |
| McClure, P | 1 |
| Peters, V | 1 |
| Saunders, F | 2 |
| Sonley, M | 1 |
| Timothy, AR | 1 |
| Jones, AE | 1 |
| Babini, L | 1 |
| Franchini, A | 1 |
| Olweny, CL | 2 |
| Katongole-Mbidde, E | 1 |
| Kiire, C | 1 |
| Lwanga, SK | 1 |
| Magrath, I | 2 |
| Ziegler, JL | 2 |
| Young, RC | 4 |
| Chabner, BA | 2 |
| Hubbard, SM | 2 |
| DeVita, VT | 4 |
| Oberlin, O | 1 |
| Leverger, G | 1 |
| Pacquement, H | 1 |
| Raquin, MA | 1 |
| Chompret, A | 1 |
| Habrand, JL | 1 |
| Terrier-Lacombe, MJ | 1 |
| Bey, P | 1 |
| Bertrand, Y | 1 |
| Rubie, H | 1 |
| Lepage, E | 1 |
| D'Agay, MF | 1 |
| Castaigne, S | 1 |
| Fermand, JP | 1 |
| Frija, J | 1 |
| Miot, C | 1 |
| Brouet, JC | 1 |
| Marty, M | 1 |
| Comer, M | 1 |
| Harvey, AR | 1 |
| Prosnitz, LR | 1 |
| Roberts, KB | 1 |
| Negretti, E | 2 |
| Zanini, M | 1 |
| Zucali, R | 1 |
| Henry-Amar, M | 2 |
| Tarayre, M | 1 |
| Carde, P | 2 |
| Thomas, J | 2 |
| Hagenbeek, A | 1 |
| Monconduit, M | 1 |
| de Pauw, BE | 1 |
| Breed, WP | 1 |
| Biti, GP | 1 |
| Cimino, G | 1 |
| Cartoni, C | 1 |
| Magrini, SM | 1 |
| Anselmo, AP | 1 |
| Enrici, RM | 1 |
| Bellesi, GP | 1 |
| Bosi, A | 1 |
| Papa, G | 1 |
| Giannarelli, D | 1 |
| Longo, DL | 1 |
| Russo, A | 1 |
| Duffey, PL | 1 |
| Glatstein, E | 1 |
| Hill, JB | 1 |
| Jaffe, ES | 1 |
| Velasquez, WS | 1 |
| McLaughlin, P | 1 |
| Redman, JR | 1 |
| Swan, F | 1 |
| Rodriguez, MA | 1 |
| North, L | 1 |
| Dixon, D | 1 |
| Silvermintz, K | 1 |
| Roach, M | 1 |
| Brophy, N | 1 |
| Cox, R | 1 |
| Varghese, A | 1 |
| Doyle, J | 1 |
| Berry, M | 1 |
| Blanchette, V | 1 |
| Chan, H | 1 |
| Doherty, M | 1 |
| Greenberg, M | 1 |
| Panzarella, T | 1 |
| Rusthoven, JJ | 1 |
| Tubiana, M | 1 |
| Hayat, M | 1 |
| Van der Schueren, E | 1 |
| Noordijk, EM | 1 |
| Tanguy, A | 1 |
| Meerwaldt, JH | 1 |
| Silingardi, V | 1 |
| Federico, M | 1 |
| Frassoldati, A | 1 |
| Barbieri, F | 1 |
| Palomba, G | 1 |
| Mauri, C | 1 |
| Vonderheid, EC | 1 |
| Tan, ET | 1 |
| Kantor, AF | 1 |
| Shrager, L | 1 |
| Micaily, B | 1 |
| Van Scott, EJ | 1 |
| Druker, BJ | 1 |
| Bernengo, MG | 1 |
| Meregalli, M | 1 |
| Jemma, C | 1 |
| Lisa, F | 1 |
| Coleman, M | 1 |
| Friedlander, RJ | 1 |
| Gordillo-Paniagua, G | 1 |
| Mora-Muñoz, A | 1 |
| Herrera-Garnica, J | 1 |
| Gordillo-de Anda, R | 1 |
| Muñoz-Arizpe, R | 1 |
| West, CD | 1 |
| Ryoo, MC | 1 |
| Kagan, AR | 1 |
| Wollin, M | 1 |
| Nussbaum, H | 1 |
| Chan, PY | 1 |
| Hintz, BL | 1 |
| Rao, AR | 1 |
| McMahon, J | 1 |
| Abel, EA | 1 |
| Sendagorta, E | 1 |
| Hu, CH | 1 |
| Kanaev, SV | 1 |
| Malinin, AP | 1 |
| Chikrizov, SI | 1 |
| Zittoun, R | 1 |
| Audebert, A | 1 |
| Hoerni, B | 1 |
| Bernadou, A | 1 |
| Krulik, M | 1 |
| Rojouan, J | 1 |
| Eghbali, H | 1 |
| Merle-Béral, H | 1 |
| Parlier, Y | 1 |
| Diebold, J | 1 |
| McLeod, DT | 1 |
| Calverley, PM | 1 |
| Schein, PS | 1 |
| McLaren, JH | 1 |
| Papac, RJ | 1 |
| Amiel, JL | 1 |
| Mathé, G | 1 |
| Mbidde, EK | 1 |
| Nkwocha, J | 1 |
| Andersen, E | 1 |
| Christensen, BE | 1 |
| Videbaek, A | 1 |
| McElwain, TJ | 1 |
| Hunter, A | 1 |
| Peckham, MJ | 1 |
| Smithers, DW | 1 |
| Fairley, GH | 1 |
| Johnson, RE | 1 |
| Cameron, JS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy[NCT00188149] | Phase 4 | 300 participants | Interventional | 2000-05-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for mechlorethamine and Recrudescence
| Article | Year |
|---|---|
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined | 2005 |
[Chemotherapy of relapsed AML and ALL].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Col | 1996 |
Hodgkin's disease: management of first relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
The management of Hodgkin's disease in relapse after primary radiation therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm S | 1992 |
Combined chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1992 |
Current approaches to the treatment of advanced-stage Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The | 1986 |
Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Hodgk | 1988 |
Immunosuppressant agents in the treatment of glomerulonephritis. 2. Cytotoxic drugs.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Antilymphocyte Serum; Antineoplastic Agents; Azath | 1971 |
26 trials available for mechlorethamine and Recrudescence
| Article | Year |
|---|---|
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival | 2004 |
Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2004 |
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 2006 |
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C | 1984 |
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combin | 1984 |
A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality T | 1984 |
Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.
Topics: Aged; Female; Humans; Male; Mechlorethamine; Neoplasms; Pleural Effusion; Propionibacterium acnes; R | 1980 |
Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1994 |
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubici | 1995 |
Nitrogen mustard therapy and nephrotic syndrome.
Topics: Alkylating Agents; Child, Preschool; Drug Resistance; Female; Humans; Infant; Male; Mechlorethamine; | 1996 |
ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1999 |
Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Topics: Abdomen; Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymph | 1977 |
New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Hum | 1977 |
Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas.
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1979 |
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Ch | 1992 |
Hodgkin's disease, clinical stages I, II A-B and IIIA. Results of brief chemotherapy followed by irradiation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1991 |
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1991 |
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; | 1992 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1986 |
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1989 |
Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
Maintenance chemotherapy for advanced Hodgkin's disease in remission.
Topics: Blood Cell Count; Blood Platelets; Hodgkin Disease; Humans; Lymphocytes; Mechlorethamine; Nitrosoure | 1973 |
International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
Topics: Biopsy; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Gold Colloid, Radioa | 1973 |
78 other studies available for mechlorethamine and Recrudescence
| Article | Year |
|---|---|
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2020 |
Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lymphoma; Lymph | 2015 |
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2015 |
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbaz | 2009 |
Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Male; | 2013 |
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2003 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 2004 |
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 2004 |
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 2005 |
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combin | 2005 |
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 2006 |
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin; | 2007 |
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Drug Therapy, Co | 1980 |
[Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood].
Topics: Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Drug Tolerance; Female; Glomerulosclerosis, | 1984 |
Hodgkin's disease in children. A ten-year experience in South Africa.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow- | 1984 |
[Treatment of recurrences of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1984 |
Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children: long-term results.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
Diagnosis and management of Hodgkin's disease in the adult.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
[Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina | 1983 |
[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophos | 1983 |
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1983 |
Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1983 |
Nitrogen mustard therapy in children with frequent-relapsing nephrotic syndrome and steroid toxicity.
Topics: Child, Preschool; Female; Glucocorticoids; Humans; Infant; Male; Mechlorethamine; Nephrotic Syndrome | 1983 |
The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Recur | 1983 |
[Treatment of recurrent aphthae with nitrogen mustard].
Topics: Humans; Injections; Mechlorethamine; Mouth Mucosa; Recurrence; Stomatitis, Aphthous | 1982 |
The treatment of mycosis fungoides with ointment-based mechlorethamine.
Topics: Administration, Topical; Dermatitis, Contact; Humans; Mechlorethamine; Mycosis Fungoides; Ointment B | 1982 |
The radiologic appearance of chemical pleurodesis.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Male; Mec | 1980 |
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1994 |
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool | 1993 |
Pediatric stage IV Hodgkin disease. Long-term survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1993 |
Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1993 |
Relapsing chickenpox in a young man with non-Hodgkin's lymphoma.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Cyclophosphamide; Doxo | 1994 |
The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1994 |
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1995 |
Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Combined Modality Therap | 1996 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An | 1997 |
[Langerhans cell histiocytosis in the elderly].
Topics: Adult; Aged; Child, Preschool; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Immunoenzy | 1998 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci | 1998 |
Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Purging; Busulfan; Combined Mod | 1999 |
In vivo expansion of reinfused autologous peripheral blood stem cells after a myeloablative regimen, as an alternative to ex vivo expansion pretransplantation: an intriguing observation in apatient autografted twice.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Cyclophosphamide; Doxoru | 1999 |
Hypopigmented mycosis fungoides: treatment and a 6(1/2)-year follow-up of 9 patients.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Asian People; Black People; Child; Female; Fol | 2000 |
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Ther | 2000 |
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; | 2001 |
Inhibition by leukocyte depletion of neointima formation after balloon angioplasty in a rabbit model of restenosis.
Topics: Angioplasty, Balloon; Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Cell Adhesion; F | 2001 |
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T | 2001 |
Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Topics: Adolescent; Adult; Bleomycin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgk | 1978 |
Total skin electron beam therapy in mycosis fungoides.
Topics: Administration, Topical; Adult; Aged; Erythema; Female; Humans; Male; Mechlorethamine; Methods; Midd | 1978 |
Stages I--III Hodgkin's disease in children: results of staging and treatment.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lym | 1977 |
Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report.
Topics: Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1979 |
Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; | 1979 |
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1978 |
Childhood Hodgkin's disease in Uganda: a ten year experience.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gynec | 1978 |
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1978 |
Remission of scleroderma during chemotherapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1992 |
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Et | 1990 |
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1991 |
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1991 |
Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1990 |
Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1990 |
Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1989 |
Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma.
Topics: Administration, Cutaneous; Age Factors; Aged; Female; Follow-Up Studies; Humans; Lymphoma; Male; Mec | 1989 |
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chlorambucil; Female; Hodg | 1989 |
Functional properties in Sézary cells with an unusual phenotype.
Topics: Aged; Antibodies, Monoclonal; Chlorambucil; Dermatitis, Exfoliative; Drug Therapy, Combination; Huma | 1985 |
[Nitrogen mustard as an alternative therapy in children with idiopathic nephrotic syndrome and recurrent infections].
Topics: Bacterial Infections; Child; Child, Preschool; Humans; Male; Mechlorethamine; Nephrotic Syndrome; Pr | 1988 |
Childhood membranoproliferative glomerulonephritis: an approach to management.
Topics: Aspirin; Azathioprine; Child; Cyclophosphamide; Dipyridamole; Drug Administration Schedule; Drug The | 1986 |
Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1987 |
PUVA treatment of erythrodermic and plaque-type mycosis fungoides. Ten-year follow-up study.
Topics: Adult; Aged; Dermatomycoses; Female; Follow-Up Studies; Humans; Male; Mechlorethamine; Middle Aged; | 1987 |
[The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
Further experience of Corynebacterium parvum in malignant pleural effusion.
Topics: Adult; Aged; Drainage; Female; Humans; Lung Neoplasms; Male; Mechlorethamine; Middle Aged; Pleural E | 1985 |
Prognosis and survival with extranodal Hodgkin's disease.
Topics: Adult; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Human | 1974 |
[Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Bleomycin; Drug Hypersensitivity; Drug Therapy, Combination; Hodgkin Disease; | 1974 |
Letter: Chemotherapy of Hodgkin's disease.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin D | 1974 |
Treatment of Hodgkin's disease. Results obtained by individualized treatment using radiotherapy and cytostatics.
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Female; Hodgkin Disease; Humans; Male; Mechloretha | 1972 |
Combination chemotherapy in advanced and recurrent Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; | 1973 |
Hodgkin's disease in childhood.
Topics: Adolescent; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Pr | 1973 |